Premium
AUTOLOGOUS STEM CELL TRANSPLANTATION IN FIRST REMISSION SIGNIFICANTLY PROLONGS PROGRESSION‐FREE AND OVERALL SURVIVAL IN MANTLE CELL LYMPHOMA
Author(s) -
Zoellner A.,
Unterhalt M.,
Stilgenbauer S.,
Hübel K.,
Thieblemont C.,
Metzner B.,
KluinNelemans H.,
Hiddemann W.,
Dreyling M.,
Hoster E.
Publication year - 2019
Publication title -
hematological oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.918
H-Index - 44
eISSN - 1099-1069
pISSN - 0278-0232
DOI - 10.1002/hon.13_2629
Subject(s) - medicine , mantle cell lymphoma , autologous stem cell transplantation , vincristine , international prognostic index , prednisone , mitoxantrone , rituximab , surgery , progression free survival , transplantation , chop , gastroenterology , cyclophosphamide , oncology , chemotherapy , lymphoma